Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global Nanomedicine Market Size and Sales Report for Period 2017 to 2023

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

In this market research report, the global Nanomedicine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2017 and 2023.

Geographically, This market research report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Nanomedicine for these regions, from 2012 to 2023 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Nanomedicine market competition by top manufacturers/players, with Nanomedicine sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
GE Healthcare
Johnson & Johnson
Mallinckrodt plc
Merck & Co. Inc.
Nanosphere Inc.
Pfizer Inc.
Sigma-Tau Pharmaceuticals Inc.
Smith & Nephew PLC
Stryker Corp
Teva Pharmaceutical Industries Ltd.
UCB (Union chimique belge) S.A
On the basis of product, This market research report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Regenerative Medicine
In-vitro & In-vivo Diagnostics
Vaccines
Drug Delivery
On the basis on the end users/applications, This market research report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Nanomedicine for each application, including
Clinical Cardiology
Urology
Genetics
Orthopedics
Ophthalmology

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents / Index:

Table of Contents/Index

Global Nanomedicine Sales Market Report 2017
1 Nanomedicine Market Overview
1.1 Product Overview and Scope of Nanomedicine
1.2 Classification of Nanomedicine by Product Category
1.2.1 Global Nanomedicine Market Size (Sales) Comparison by Type (2012-2023)
1.2.2 Global Nanomedicine Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Regenerative Medicine
1.2.4 In-vitro & In-vivo Diagnostics
1.2.5 Vaccines
1.2.6 Drug Delivery
1.3 Global Nanomedicine Market by Application/End Users
1.3.1 Global Nanomedicine Sales (Volume) and Market Share Comparison by Application (2012-2023)
1.3.2 Clinical Cardiology
1.3.3 Urology
1.3.4 Genetics
1.3.5 Orthopedics
1.3.6 Ophthalmology
1.4 Global Nanomedicine Market by Region
1.4.1 Global Nanomedicine Market Size (Value) Comparison by Region (2012-2023)
1.4.2 United States Nanomedicine Status and Prospect (2012-2023)
1.4.3 China Nanomedicine Status and Prospect (2012-2023)
1.4.4 Europe Nanomedicine Status and Prospect (2012-2023)
1.4.5 Japan Nanomedicine Status and Prospect (2012-2023)
1.4.6 Southeast Asia Nanomedicine Status and Prospect (2012-2023)
1.4.7 India Nanomedicine Status and Prospect (2012-2023)
1.5 Global Market Size (Value and Volume) of Nanomedicine (2012-2023)
1.5.1 Global Nanomedicine Sales and Growth Rate (2012-2023)
1.5.2 Global Nanomedicine Revenue and Growth Rate (2012-2023)

2 Global Nanomedicine Competition by Players/Suppliers, Type and Application
2.1 Global Nanomedicine Market Competition by Players/Suppliers
2.1.1 Global Nanomedicine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Nanomedicine Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Nanomedicine (Volume and Value) by Type
2.2.1 Global Nanomedicine Sales and Market Share by Type (2012-2017)
2.2.2 Global Nanomedicine Revenue and Market Share by Type (2012-2017)
2.3 Global Nanomedicine (Volume and Value) by Region
2.3.1 Global Nanomedicine Sales and Market Share by Region (2012-2017)
2.3.2 Global Nanomedicine Revenue and Market Share by Region (2012-2017)
2.4 Global Nanomedicine (Volume) by Application

3 United States Nanomedicine (Volume, Value and Sales Price)
3.1 United States Nanomedicine Sales and Value (2012-2017)
3.1.1 United States Nanomedicine Sales and Growth Rate (2012-2017)
3.1.2 United States Nanomedicine Revenue and Growth Rate (2012-2017)
3.1.3 United States Nanomedicine Sales Price Trend (2012-2017)
3.2 United States Nanomedicine Sales Volume and Market Share by Players
3.3 United States Nanomedicine Sales Volume and Market Share by Type
3.4 United States Nanomedicine Sales Volume and Market Share by Application

4 China Nanomedicine (Volume, Value and Sales Price)
4.1 China Nanomedicine Sales and Value (2012-2017)
4.1.1 China Nanomedicine Sales and Growth Rate (2012-2017)
4.1.2 China Nanomedicine Revenue and Growth Rate (2012-2017)
4.1.3 China Nanomedicine Sales Price Trend (2012-2017)
4.2 China Nanomedicine Sales Volume and Market Share by Players
4.3 China Nanomedicine Sales Volume and Market Share by Type
4.4 China Nanomedicine Sales Volume and Market Share by Application

5 Europe Nanomedicine (Volume, Value and Sales Price)
5.1 Europe Nanomedicine Sales and Value (2012-2017)
5.1.1 Europe Nanomedicine Sales and Growth Rate (2012-2017)
5.1.2 Europe Nanomedicine Revenue and Growth Rate (2012-2017)
5.1.3 Europe Nanomedicine Sales Price Trend (2012-2017)
5.2 Europe Nanomedicine Sales Volume and Market Share by Players
5.3 Europe Nanomedicine Sales Volume and Market Share by Type
5.4 Europe Nanomedicine Sales Volume and Market Share by Application

6 Japan Nanomedicine (Volume, Value and Sales Price)
6.1 Japan Nanomedicine Sales and Value (2012-2017)
6.1.1 Japan Nanomedicine Sales and Growth Rate (2012-2017)
6.1.2 Japan Nanomedicine Revenue and Growth Rate (2012-2017)
6.1.3 Japan Nanomedicine Sales Price Trend (2012-2017)
6.2 Japan Nanomedicine Sales Volume and Market Share by Players
6.3 Japan Nanomedicine Sales Volume and Market Share by Type
6.4 Japan Nanomedicine Sales Volume and Market Share by Application

7 Southeast Asia Nanomedicine (Volume, Value and Sales Price)
7.1 Southeast Asia Nanomedicine Sales and Value (2012-2017)
7.1.1 Southeast Asia Nanomedicine Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Nanomedicine Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Nanomedicine Sales Price Trend (2012-2017)
7.2 Southeast Asia Nanomedicine Sales Volume and Market Share by Players
7.3 Southeast Asia Nanomedicine Sales Volume and Market Share by Type
7.4 Southeast Asia Nanomedicine Sales Volume and Market Share by Application

8 India Nanomedicine (Volume, Value and Sales Price)
8.1 India Nanomedicine Sales and Value (2012-2017)
8.1.1 India Nanomedicine Sales and Growth Rate (2012-2017)
8.1.2 India Nanomedicine Revenue and Growth Rate (2012-2017)
8.1.3 India Nanomedicine Sales Price Trend (2012-2017)
8.2 India Nanomedicine Sales Volume and Market Share by Players
8.3 India Nanomedicine Sales Volume and Market Share by Type
8.4 India Nanomedicine Sales Volume and Market Share by Application

9 Global Nanomedicine Players/Suppliers Profiles and Sales Data
9.1 GE Healthcare
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Nanomedicine Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 GE Healthcare Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Johnson & Johnson
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Nanomedicine Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Johnson & Johnson Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Mallinckrodt plc
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Nanomedicine Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Mallinckrodt plc Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Merck & Co. Inc.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Nanomedicine Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Merck & Co. Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Nanosphere Inc.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Nanomedicine Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Nanosphere Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Pfizer Inc.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Nanomedicine Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Pfizer Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Sigma-Tau Pharmaceuticals Inc.
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Nanomedicine Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Sigma-Tau Pharmaceuticals Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Smith & Nephew PLC
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Nanomedicine Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Smith & Nephew PLC Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Stryker Corp
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Nanomedicine Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Stryker Corp Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Teva Pharmaceutical Industries Ltd.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Nanomedicine Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Teva Pharmaceutical Industries Ltd. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 UCB (Union chimique belge) S.A

10 Nanomedicine Maufacturing Cost Analysis
10.1 Nanomedicine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Nanomedicine
10.3 Manufacturing Process Analysis of Nanomedicine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Nanomedicine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Nanomedicine Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Nanomedicine Market Forecast (2017-2023)
14.1 Global Nanomedicine Sales Volume, Revenue and Price Forecast (2017-2023)
14.1.1 Global Nanomedicine Sales Volume and Growth Rate Forecast (2017-2023)
14.1.2 Global Nanomedicine Revenue and Growth Rate Forecast (2017-2023)
14.1.3 Global Nanomedicine Price and Trend Forecast (2017-2023)
14.2 Global Nanomedicine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2023)
14.2.1 Global Nanomedicine Sales Volume and Growth Rate Forecast by Regions (2017-2023)
14.2.2 Global Nanomedicine Revenue and Growth Rate Forecast by Regions (2017-2023)
14.2.3 United States Nanomedicine Sales Volume, Revenue and Growth Rate Forecast (2017-2023)
14.2.4 China Nanomedicine Sales Volume, Revenue and Growth Rate Forecast (2017-2023)
14.2.5 Europe Nanomedicine Sales Volume, Revenue and Growth Rate Forecast (2017-2023)
14.2.6 Japan Nanomedicine Sales Volume, Revenue and Growth Rate Forecast (2017-2023)
14.2.7 Southeast Asia Nanomedicine Sales Volume, Revenue and Growth Rate Forecast (2017-2023)
14.2.8 India Nanomedicine Sales Volume, Revenue and Growth Rate Forecast (2017-2023)
14.3 Global Nanomedicine Sales Volume, Revenue and Price Forecast by Type (2017-2023)
14.3.1 Global Nanomedicine Sales Forecast by Type (2017-2023)
14.3.2 Global Nanomedicine Revenue Forecast by Type (2017-2023)
14.3.3 Global Nanomedicine Price Forecast by Type (2017-2023)
14.4 Global Nanomedicine Sales Volume Forecast by Application (2017-2023)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 27995

Category: 11

Published date: 2017-09-13 16:23:14

Number of Pages: 134

Publisher Name: QYResearch

Over all Rating: 90 % (Average of Ratings provided by clients)